+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

AI-Powered Pathology Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6144261
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The AI-Powered Pathology Market is projected to reach USD 128.87 Million in 2026. It is expected to continue growing at a CAGR of 7.76%, reaching USD 201.22 Million by 2032.

AI-Powered Pathology: Executive Overview

AI-powered pathology applies machine learning, computer vision, and digital workflows to the analysis of pathology images and related clinical data. Its principal value lies in supporting detection, classification, quantification, quality assurance, and workflow coordination while keeping diagnostic responsibility with qualified professionals. Adoption depends on the availability of digitized slides, interoperable systems, validated algorithms, secure data governance, and workforce readiness.

Digital Workflows Are Reshaping Pathology Practice

The field is shifting from microscope-centered processes toward digitally enabled, connected workflows. Whole-slide imaging, remote consultation, structured reporting, laboratory information systems, and algorithm-assisted review are becoming more closely integrated. These changes can improve consistency and traceability, but implementation remains sensitive to scanner performance, image standards, laboratory infrastructure, reimbursement arrangements, regulatory requirements, and the need to validate tools across diverse specimen types and patient populations.

Artificial Intelligence Expands Analytical and Operational Support

Artificial intelligence can assist with image triage, tissue and cell recognition, biomarker interpretation, grading, quantification, and identification of cases requiring additional review. It can also support workload prioritization, quality checks, and standardized documentation. The cumulative impact is strongest when algorithms complement rather than replace pathologists. Key safeguards include representative training data, explainable outputs, monitoring for performance drift, cybersecurity controls, human oversight, and prospective validation in routine clinical settings.

Regional Conditions Determine the Pace of Adoption

North America benefits from advanced digital-health infrastructure, established research capacity, and growing clinical interest in algorithm-supported diagnostics, while regulatory and reimbursement evidence requirements shape deployment. Europe combines strong academic and healthcare networks with stringent privacy, medical-device, and cross-border data obligations. Asia-Pacific spans highly digitized systems and capacity-constrained settings, creating varied adoption pathways and a strong role for scalable platforms. Latin America is advancing through reference laboratories, telepathology, and public-private initiatives, although connectivity, funding, and interoperability remain uneven. The Middle East is investing in healthcare modernization and centralized diagnostic capability, while workforce development and data governance remain important. Africa presents substantial opportunities for remote expertise, task prioritization, and access improvement, but adoption is constrained in many settings by infrastructure, slide digitization capacity, and specialist availability.

Economic and Security Groupings Create Distinct Policy Contexts

ASEAN members are exploring digital-health collaboration while differing in regulatory maturity, infrastructure, and specialist capacity. BRICS economies bring substantial clinical demand, research activity, and varied public-health priorities, but data standards and procurement approaches are not uniform. The European Union emphasizes harmonized governance, privacy, interoperability, and evidence for trustworthy medical AI. G7 countries generally combine strong research ecosystems with demanding safety, cybersecurity, and clinical-validation expectations. GCC states are using coordinated healthcare modernization efforts to strengthen specialized services and digital infrastructure. NATO members may benefit from resilient health-information practices and cross-border technical collaboration, although civilian diagnostic deployment remains governed by national healthcare and medical-device frameworks.

Country-Level Readiness Reflects Infrastructure, Regulation, and Clinical Need

Australia and Canada have strong research and healthcare institutions, with adoption shaped by dispersed populations, specialist access, and evidence requirements. Brazil and Mexico are developing digital pathology capacity amid varied regional infrastructure and public-private health provision. China, India, Japan, and South Korea combine significant technical capability with distinct regulatory, procurement, language, and data-governance environments. France, Germany, Italy, Spain, and the United Kingdom are progressing within mature healthcare systems where validation, interoperability, privacy, procurement, and workforce acceptance are central. Russia’s pathway is influenced by domestic technology priorities, healthcare-system variation, and data-governance considerations. Across these countries, successful implementation requires local validation, integration with laboratory workflows, and clear accountability for final diagnostic decisions.

Prioritize Validated, Interoperable, and Human-Centered Deployment

Industry leaders should begin with high-value use cases that have measurable clinical and operational objectives, then validate performance on local specimens and across relevant demographic groups. Investments should pair scanners, storage, connectivity, laboratory information systems, and cybersecurity with training for pathologists, laboratory staff, and clinical users. Governance should define approval thresholds, audit trails, escalation procedures, bias monitoring, and responsibility for discordant results. Organizations should also establish procurement standards for interoperability and lifecycle support, measure real-world outcomes rather than relying solely on technical accuracy, and use phased implementation with continuous post-deployment review.

Methodology for a Evidence-Based AI Pathology Assessment

This executive summary uses a structured qualitative assessment of AI-powered pathology across technology, clinical workflow, regulation, infrastructure, workforce, data governance, and regional adoption conditions. Findings are derived from established characteristics of digital pathology and artificial intelligence deployment rather than market estimates or forecasts. Regional, group, and country comparisons consider healthcare-system maturity, digitization readiness, specialist access, policy environment, interoperability, and implementation constraints. Conclusions are framed as evidence-based strategic implications and should be complemented by local validation, regulatory review, and institution-specific feasibility analysis.

Responsible Integration Will Define the Next Phase of Pathology

AI-powered pathology is moving toward integrated decision support, quality management, and distributed expertise rather than autonomous diagnosis. The strongest results will come from combining validated algorithms with high-quality digital infrastructure, robust governance, skilled professionals, and workflows designed around patient safety. Leaders that treat deployment as a clinical transformation program-rather than a software purchase-will be better positioned to improve consistency, access, and operational resilience while preserving professional accountability.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. AI-Powered Pathology Market, by Offering
7.1. Introduction
7.2. Hardware
7.2.1. Scanners
7.2.1.1. Tissue Microarray
7.2.1.2. Whole Slide Imaging
7.2.2. Workstations
7.2.2.1. Clinical Workstations
7.2.2.2. Pathology Workstations
7.3. Services
7.3.1. Consulting
7.3.2. Support
7.3.3. Training
7.3.3.1. Online Training
7.3.3.2. Onsite Training
7.4. Software
8. AI-Powered Pathology Market, by Application
8.1. Introduction
8.2. Diagnostics
8.2.1. Cancer Diagnosis
8.2.2. Histopathology Analysis
8.2.2.1. Cell Counting
8.2.2.2. Tissue Classification
8.2.3. Infectious Disease Detection
8.3. Drug Discovery
8.4. Prognosis
9. AI-Powered Pathology Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.2.1. Pathology Labs
9.2.2. Research Labs
9.3. Hospitals
9.3.1. Large Hospitals
9.3.2. Small Clinics
9.4. Pharmaceutical Biotech
9.4.1. Biopharmaceutical Companies
9.4.2. Clinical Research Organizations
10. AI-Powered Pathology Market, by Deployment
10.1. Introduction
10.2. Cloud
10.2.1. Private Cloud
10.2.2. Public Cloud
10.3. Hybrid
10.3.1. Cloud Bursting
10.3.2. Multi Cloud
10.4. On-Premise
10.4.1. Enterprise Servers
10.4.2. Local Servers
11. AI-Powered Pathology Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. AI-Powered Pathology Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. AI-Powered Pathology Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. aetherAI Co., Ltd.
15.2. Aiforia Technologies Oyj
15.3. Aignostics GmbH
15.4. AIRA Matrix Private Limited
15.5. Deep Bio Co., Ltd.
15.6. Ibex Medical Analytics Ltd.
15.7. Indica Labs, Inc.
15.8. Koninklijke Philips N.V.
15.9. Mindpeak GmbH
15.10. Paige.AI, Inc.
15.11. PathAI, Inc.
15.12. Proscia, Inc.
15.13. Tribun Health SAS
15.14. Ventana Medical Systems, Inc.
15.15. Visiopharm A/S
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global AI-Powered Pathology Market, Years Considered for the Study
FIGURE 2. Global AI-Powered Pathology Market, Research Design
FIGURE 3. Global AI-Powered Pathology Market, Research Framework
FIGURE 4. Global AI-Powered Pathology Market, Data Triangulation
FIGURE 5. Global AI-Powered Pathology Market Size, 2017-2032 (USD Million)
FIGURE 6. Global AI-Powered Pathology Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 7. Global AI-Powered Pathology Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global AI-Powered Pathology Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global AI-Powered Pathology Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global AI-Powered Pathology Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global AI-Powered Pathology Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global AI-Powered Pathology Market Size, by Deployment, 2025 vs 2032 (%)
FIGURE 13. Global AI-Powered Pathology Market Size, by Deployment, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global AI-Powered Pathology Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global AI-Powered Pathology Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global AI-Powered Pathology Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global AI-Powered Pathology Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global AI-Powered Pathology Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global AI-Powered Pathology Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global AI-Powered Pathology Market Segmentation & Coverage
TABLE 2. Global AI-Powered Pathology Market Size, 2017-2032 (USD Million)
TABLE 3. Global AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 4. Global Hardware Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hardware Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hardware Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Scanners Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Scanners Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Scanners Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Tissue Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Tissue Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Tissue Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Whole Slide Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Whole Slide Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Whole Slide Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Workstations Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Workstations Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Workstations Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Clinical Workstations Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Clinical Workstations Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Clinical Workstations Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Pathology Workstations Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Pathology Workstations Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Pathology Workstations Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Consulting Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Consulting Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Consulting Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Training Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Training Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Training Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Online Training Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Online Training Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Online Training Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Onsite Training Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Onsite Training Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Onsite Training Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 47. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Cancer Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Cancer Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Cancer Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Histopathology Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Histopathology Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Histopathology Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Cell Counting Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Cell Counting Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Cell Counting Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Tissue Classification Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Tissue Classification Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Tissue Classification Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Infectious Disease Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Infectious Disease Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Infectious Disease Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Prognosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Prognosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Prognosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Pathology Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Pathology Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Pathology Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Research Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Research Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Research Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Large Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Large Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Large Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Small Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Small Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Small Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Pharmaceutical Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Pharmaceutical Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Biopharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Biopharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Biopharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Clinical Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Clinical Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Clinical Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 100. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Hybrid Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Hybrid Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Hybrid Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Cloud Bursting Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Cloud Bursting Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Cloud Bursting Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Multi Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Multi Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Multi Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global On-Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global On-Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global On-Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Enterprise Servers Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Enterprise Servers Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Enterprise Servers Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Local Servers Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Local Servers Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Local Servers Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global AI-Powered Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific AI-Powered Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 146. North America AI-Powered Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. North America AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 148. North America AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 149. North America AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 150. North America AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 151. North America AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 152. North America AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 153. North America AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. North America AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 155. North America AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 156. North America AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. North America AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 158. North America AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 159. North America AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 160. North America AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 161. North America AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 162. North America AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 163. North America AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 164. Latin America AI-Powered Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Latin America AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 166. Latin America AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 167. Latin America AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 168. Latin America AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 169. Latin America AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 170. Latin America AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 171. Latin America AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Latin America AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 173. Latin America AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 174. Latin America AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Latin America AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 176. Latin America AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 177. Latin America AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 178. Latin America AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 179. Latin America AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 180. Latin America AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 181. Latin America AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 182. Europe AI-Powered Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Europe AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 184. Europe AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 185. Europe AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 186. Europe AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 187. Europe AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 188. Europe AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 189. Europe AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Europe AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 191. Europe AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 192. Europe AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Europe AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 194. Europe AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 195. Europe AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 196. Europe AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 197. Europe AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 198. Europe AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 199. Europe AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 200. Middle East AI-Powered Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Middle East AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 202. Middle East AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 203. Middle East AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 204. Middle East AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 205. Middle East AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 206. Middle East AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 207. Middle East AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Middle East AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 209. Middle East AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 210. Middle East AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Middle East AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 212. Middle East AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 213. Middle East AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 214. Middle East AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 215. Middle East AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 216. Middle East AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 217. Middle East AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 218. Africa AI-Powered Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Africa AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 220. Africa AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 221. Africa AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 222. Africa AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 223. Africa AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 224. Africa AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 225. Africa AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Africa AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 227. Africa AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 228. Africa AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Africa AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 230. Africa AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. Africa AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 232. Africa AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 233. Africa AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 234. Africa AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 235. Africa AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 236. Global AI-Powered Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 237. ASEAN AI-Powered Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. ASEAN AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 239. ASEAN AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 240. ASEAN AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 241. ASEAN AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 242. ASEAN AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 243. ASEAN AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 244. ASEAN AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. ASEAN AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 246. ASEAN AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 247. ASEAN AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. ASEAN AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 249. ASEAN AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 250. ASEAN AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 251. ASEAN AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 252. ASEAN AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 253. ASEAN AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 254. ASEAN AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 255. GCC AI-Powered Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. GCC AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 257. GCC AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 258. GCC AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 259. GCC AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 260. GCC AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 261. GCC AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 262. GCC AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. GCC AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 264. GCC AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 265. GCC AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. GCC AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 267. GCC AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 268. GCC AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 269. GCC AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 270. GCC AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 271. GCC AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 272. GCC AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 273. European Union AI-Powered Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. European Union AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 275. European Union AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 276. European Union AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 277. European Union AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 278. European Union AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 279. European Union AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 280. European Union AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. European Union AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 282. European Union AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 283. European Union AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. European Union AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 285. European Union AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 286. European Union AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 287. European Union AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 288. European Union AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 289. European Union AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 290. European Union AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 291. BRICS AI-Powered Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 292. BRICS AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 293. BRICS AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 294. BRICS AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 295. BRICS AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 296. BRICS AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 297. BRICS AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 298. BRICS AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. BRICS AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 300. BRICS AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 301. BRICS AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 302. BRICS AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 303. BRICS AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 304. BRICS AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 305. BRICS AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 306. BRICS AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 307. BRICS AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 308. BRICS AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 309. G7 AI-Powered Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. G7 AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 311. G7 AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 312. G7 AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 313. G7 AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 314. G7 AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 315. G7 AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 316. G7 AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. G7 AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 318. G7 AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 319. G7 AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. G7 AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 321. G7 AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 322. G7 AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 323. G7 AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 324. G7 AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 325. G7 AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 326. G7 AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 327. NATO AI-Powered Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 328. NATO AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 329. NATO AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 330. NATO AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 331. NATO AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 332. NATO AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 333. NATO AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 334. NATO AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. NATO AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 336. NATO AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 337. NATO AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 338. NATO AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 339. NATO AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 340. NATO AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 341. NATO AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 342. NATO AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 343. NATO AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 344. NATO AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 345. Global AI-Powered Pathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 346. United States AI-Powered Pathology Market Size, 2017-2032 (USD Million)
TABLE 347. United States AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 348. United States AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 349. United States AI-Powered Pathology Market Size, by Scanners, 2017-2032 (USD Million)
TABLE 350. United States AI-Powered Pathology Market Size, by Workstations, 2017-2032 (USD Million)
TABLE 351. United States AI-Powered Pathology Market Size, by Services, 2017-2032 (USD Million)
TABLE 352. United States AI-Powered Pathology Market Size, by Training, 2017-2032 (USD Million)
TABLE 353. United States AI-Powered Pathology Market Size, by Application, 2017-2032 (USD Million)
TABLE 354. United States AI-Powered Pathology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 355. United States AI-Powered Pathology Market Size, by Histopathology Analysis, 2017-2032 (USD Million)
TABLE 356. United States AI-Powered Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 357. United States AI-Powered Pathology Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 358. United States AI-Powered Pathology Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 359. United States AI-Powered Pathology Market Size, by Pharmaceutical Biotech, 2017-2032 (USD Million)
TABLE 360. United States AI-Powered Pathology Market Size, by Deployment, 2017-2032 (USD Million)
TABLE 361. United States AI-Powered Pathology Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 362. United States AI-Powered Pathology Market Size, by Hybrid, 2017-2032 (USD Million)
TABLE 363. United States AI-Powered Pathology Market Size, by On-Premise, 2017-2032 (USD Million)
TABLE 364. Canada AI-Powered Pathology Market Size, 2017-2032 (USD Million)
TABLE 365. Canada AI-Powered Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 366. Canada AI-Powered Pathology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 367. Canada AI-Powered Pathology Market Size, by Sca

Companies Mentioned

  • aetherAI Co., Ltd.
  • Aiforia Technologies Oyj
  • Aignostics GmbH
  • AIRA Matrix Private Limited
  • Deep Bio Co., Ltd.
  • Ibex Medical Analytics Ltd.
  • Indica Labs, Inc.
  • Koninklijke Philips N.V.
  • Mindpeak GmbH
  • Paige.AI, Inc.
  • PathAI, Inc.
  • Proscia, Inc.
  • Tribun Health SAS
  • Ventana Medical Systems, Inc.
  • Visiopharm A/S